Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Exagen (XGN) Leases (2022 - 2026)

Exagen filings provide 5 years of Leases readings, the most recent being $2.6 million for Q1 2026.

  • On a quarterly basis, Leases rose 19.93% to $2.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $2.6 million, a 19.93% increase, with the full-year FY2025 number at $1.4 million, up 195.27% from a year prior.
  • Leases hit $2.6 million in Q1 2026 for Exagen, up from $1.4 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $5.1 million in Q3 2022 to a low of $486000.0 in Q4 2024.
  • Median Leases over the past 5 years was $2.6 million (2024), compared with a mean of $2.7 million.
  • Biggest five-year swings in Leases: skyrocketed 239.49% in 2023 and later crashed 85.21% in 2024.
  • Exagen's Leases stood at $1.4 million in 2022, then surged by 130.27% to $3.3 million in 2023, then crashed by 85.21% to $486000.0 in 2024, then soared by 195.27% to $1.4 million in 2025, then soared by 81.18% to $2.6 million in 2026.
  • The last three reported values for Leases were $2.6 million (Q1 2026), $1.4 million (Q4 2025), and $2.9 million (Q3 2025) per Business Quant data.